This chemical is usually referred to either as B-22 or QUCHIC or SGT-32,big brother 22,5f-pb-22,spice drug wiki,5-fluoro pb-22 3-carboxyindole.
QUCHIC (BB-22, SGT-32 or 1-(cyclohexylmethyl)-1H-indole-3-carboxylic acid 8-quinolinyl ester) is a designer drug offered by online vendors as a cannabimimetic agent, and was first detected being sold in synthetic cannabis products in Japan in early 2013, and subsequently also in New Zealand.
The structure of QUCHIC appears to use an understanding of structure-activity relationships within the indole class of cannabimimetics, although its design origins are unclear.
QUCHIC, along with QUPIC, represents a structurally unique synthetic cannabinoid chemotype since it contains an ester linker at the indole 3-position rather than the precedented ketone of JWH-018 and its analogues, or the amide of SDB-001 and its analogues.
It has a molecular formula of C25H24N2O2 and an IUPAC listing of 1-(cyclohexylmethyl)-1H-indole-3-carboxylic acid 8-quinolinyl ester.
Because of how new this chemical is, there still isn’t much information published about it.
However, many researchers have noted that B-22’s structure is especially interesting because of the way it relates to its activities.big brother 22,5-fluoro pb-22 3-carboxyindole
The compound is part of the indole class of cannabimimetics, but it bears a unique synthetic chemotype because synthesizers have substituted an ester linker at the indole’s 3-position in place of the usual JWH-018 ketone.
This product is not for human consumption, and therefore we suggest that you take the necessary precautions when dealing with it in anyway.spice drug wiki
Must be over 18 to purchase.5f-pb-22
BB-22 / QUCHIC CANNABINOID can only be ordered if you are over 18 years of age.
Please ensure that BB-22 / QUCHIC CANNABINOID is NOT controlled in the country/state to which you wish it to be delivered.
BB-22 / QUCHIC CANNABINOID is not for human consumption.BB-22 QUCHIC or SGT-32 QUCHIC
Two new-type cannabimimetic quinolinyl carboxylates, QUPIC and QUCHIC, two new cannabimimetic carboxamide derivatives, ADB-FUBINACA and ADBICA, and five synthetic cannabinoids